Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Phenoxybenzoic acid is a phenoxybenzoic acid in which the phenoxy group is para to the carboxy group. It is a white to slightly yellow crystalline powder with unique chemical properties.

2215-77-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2215-77-2 Structure
  • Basic information

    1. Product Name: 4-PHENOXYBENZOIC ACID
    2. Synonyms: 4-phenoxy-benzoicaci;Benzoic acid, p-phenoxy-;RARECHEM AL BO 0319;P-PHENOXYBENZOIC ACID;TIMTEC-BB SBB000542;4-PHENOXYBENZOIC ACID;LABOTEST-BB LT00454671;DIPHENYL ETHER 4-CARBOXYLIC ACID
    3. CAS NO:2215-77-2
    4. Molecular Formula: C13H10O3
    5. Molecular Weight: 214.22
    6. EINECS: 218-682-5
    7. Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;C13 to C42+;Carbonyl Compounds;Carboxylic Acids;NULL
    8. Mol File: 2215-77-2.mol
  • Chemical Properties

    1. Melting Point: 163-165 °C(lit.)
    2. Boiling Point: 314.35°C (rough estimate)
    3. Flash Point: 141.7 °C
    4. Appearance: White to slightly yellow/Crystalline Powder
    5. Density: 1.1956 (rough estimate)
    6. Vapor Pressure: 6.07E-06mmHg at 25°C
    7. Refractive Index: 1.5090 (estimate)
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: Very faint turbidity in hot methanol.
    10. PKA: 4.57(at 25℃)
    11. Sensitive: Air Sensitive
    12. BRN: 2212463
    13. CAS DataBase Reference: 4-PHENOXYBENZOIC ACID(CAS DataBase Reference)
    14. NIST Chemistry Reference: 4-PHENOXYBENZOIC ACID(2215-77-2)
    15. EPA Substance Registry System: 4-PHENOXYBENZOIC ACID(2215-77-2)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-37/39-36/37/39-36
    4. WGK Germany: 3
    5. RTECS: DH6293620
    6. TSCA: Yes
    7. HazardClass: IRRITANT
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 2215-77-2(Hazardous Substances Data)

2215-77-2 Usage

Uses

Used in Pharmaceutical Industry:
4-Phenoxybenzoic acid is used as an intermediate for Sitafloxacin, a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. This makes it a valuable component in the development of new antibiotics to combat bacterial infections.
Used in Antiviral Applications:
4-Phenoxybenzoic acid is used as an antiviral agent for blocking DNA binding of the human papillomavirus (HPV) E2 protein. This application highlights its potential in preventing the progression of HPV infections and associated diseases.

Safety Profile

A poison by intravenous route. When heated to decomposition it emits acrid smoke and irritating vapors.

Check Digit Verification of cas no

The CAS Registry Mumber 2215-77-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,1 and 5 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2215-77:
(6*2)+(5*2)+(4*1)+(3*5)+(2*7)+(1*7)=62
62 % 10 = 2
So 2215-77-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H10O3/c14-13(15)10-6-8-12(9-7-10)16-11-4-2-1-3-5-11/h1-9H,(H,14,15)/p-1

2215-77-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A17998)  4-Phenoxybenzoic acid, 99%   

  • 2215-77-2

  • 5g

  • 373.0CNY

  • Detail
  • Alfa Aesar

  • (A17998)  4-Phenoxybenzoic acid, 99%   

  • 2215-77-2

  • 25g

  • 1352.0CNY

  • Detail
  • Alfa Aesar

  • (A17998)  4-Phenoxybenzoic acid, 99%   

  • 2215-77-2

  • 100g

  • 3010.0CNY

  • Detail

2215-77-2Synthetic route

methyl 4-phenoxybenzoate
21218-94-0

methyl 4-phenoxybenzoate

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
Stage #1: methyl 4-phenoxybenzoate With water; sodium hydroxide In 1,4-dioxane at 20℃;
Stage #2: With hydrogenchloride In water
100%
With water; sodium hydroxide In ethanol at 20 - 70℃; for 1h;95%
With titanium(IV) oxide; dihydrogen peroxide; sodium hydroxide at 50℃; for 5h; Temperature;92%
4-phenoxybenzonitrile
3096-81-9

4-phenoxybenzonitrile

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With dihydrogen peroxide; potassium hydroxide In methanol; ethanol for 4.5h; Reflux;96%
With potassium phosphate buffer at 30℃; for 72h; Rhodococcus sp. AJ270 cells;59.3%
With potassium hydroxide
carbon monoxide
201230-82-2

carbon monoxide

4-phenoxyanilin
139-59-3

4-phenoxyanilin

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With tert.-butylnitrite; methanesulfonic acid; Ru(2,2'-bipyridine)3Cl2·6H2O; water In acetonitrile at 20℃; for 16h; Autoclave; Irradiation;95%
para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

phenol
108-95-2

phenol

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 110℃; for 12h;92%
Stage #1: phenol With sodium hydroxide In water at 60℃; for 2h;
Stage #2: para-chlorobenzoic acid In tetralin at 150℃; for 10h; Temperature;
89%
carbon monoxide
201230-82-2

carbon monoxide

4-phenoxybenzene-1-diazonium tetrafluoroborate

4-phenoxybenzene-1-diazonium tetrafluoroborate

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With Ru(2,2'-bipyridine)3Cl2·6H2O; water In acetonitrile at 20℃; under 7500.75 Torr; for 3h; Autoclave; Irradiation;91%
Ethyl 4-hydroxybenzoate
120-47-8

Ethyl 4-hydroxybenzoate

fluorobenzene
462-06-6

fluorobenzene

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
Stage #1: Ethyl 4-hydroxybenzoate; fluorobenzene With potassium carbonate In N,N-dimethyl-formamide at 100℃; for 12h;
Stage #2: With lithium hydroxide In tetrahydrofuran; methanol at 20℃; for 0.5h;
90%
4-phenoxybenzoic acid ethyl ester
31994-68-0

4-phenoxybenzoic acid ethyl ester

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With water; sodium hydroxide In tetrahydrofuran; ethanol Reflux;89%
With water; sodium hydroxide In ethanol for 3h; Reflux;87%
With sodium hydroxide In ethanol; water for 3h; Reflux;75%
4-phenoxyphenylglyoxal
70-97-3

4-phenoxyphenylglyoxal

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With iodine; dimethyl sulfoxide at 180℃; for 0.0833333h; Inert atmosphere; Microwave irradiation;88%
4-Bromodiphenyl ether
101-55-3

4-Bromodiphenyl ether

carbon dioxide
124-38-9

carbon dioxide

A

diphenylether
101-84-8

diphenylether

B

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With 1,2-bis(diphenylphosphino)ethane nickel(II) chloride In tetrahydrofuran; N,N,N,N,N,N-hexamethylphosphoric triamide for 10h; Ambient temperature; electrochemically;A 1 mmol
B 86%
1-(4-ethynylphenoxy)benzene
4200-06-0

1-(4-ethynylphenoxy)benzene

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With Oxone; trifluoroacetic acid In 1,4-dioxane for 10h; Reflux; Green chemistry;83%
4-phenoxyacetophenone
5031-78-7

4-phenoxyacetophenone

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With hydrogenchloride; sodium hypochlorite In ethanol; water80%
With potassium hypochlorite
With sodium hydroxide; water; bromine In ethanol at 40℃; for 3h;
2-chloro-1-(4-(phenoxy)phenyl)ethanone
13075-63-3

2-chloro-1-(4-(phenoxy)phenyl)ethanone

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With sodium hypochlorite; trimethylbenzylammonium bromide; sodium hydroxide In dichloromethane at 0 - 20℃;76.7%
carbon dioxide
124-38-9

carbon dioxide

2-(4-phenoxyphenyl)-5,5-dimethyl-1,3,2-dioxaborinane

2-(4-phenoxyphenyl)-5,5-dimethyl-1,3,2-dioxaborinane

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
Stage #1: carbon dioxide; 5,5-dimethyl-2-(4-phenoxyphenyl)-1,3,2-dioxaborinane With potassium tert-butylate; silver(I) acetate; triphenylphosphine In 1,4-dioxane at 100℃; under 15201 Torr; for 8h; Inert atmosphere; Autoclave;
Stage #2: With hydrogenchloride In tetrahydrofuran; water Inert atmosphere;
75%
4-Bromodiphenyl ether
101-55-3

4-Bromodiphenyl ether

carbon dioxide
124-38-9

carbon dioxide

potassium carbonate
584-08-7

potassium carbonate

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With nickel(II) bromide dimethoxyethane; 2.9-dimethyl-1,10-phenanthroline; diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; C60H36N2 In N,N-dimethyl-formamide at 20℃; for 24h; Molecular sieve; Irradiation;68%
1-(4-phenoxyphenyl)cyclohexan-1-ol

1-(4-phenoxyphenyl)cyclohexan-1-ol

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With iron(III) chloride; cerium(III) chloride; tetrabutyl-ammonium chloride; oxygen In acetonitrile at 20℃; under 760.051 Torr; for 24h; Schlenk technique; Irradiation;58%
n-butyllithium
109-72-8, 29786-93-4

n-butyllithium

4-Bromodiphenyl ether
101-55-3

4-Bromodiphenyl ether

diethyl ether
60-29-7

diethyl ether

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
at 26℃; anschliessende Behandlung mit festem CO2;
n-butyllithium
109-72-8, 29786-93-4

n-butyllithium

diethyl ether
60-29-7

diethyl ether

4-phenoxyiodobenzene
2974-94-9

4-phenoxyiodobenzene

A

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

B

5-iodo-2-phenoxy-benzoic acid
69199-91-3

5-iodo-2-phenoxy-benzoic acid

Conditions
ConditionsYield
at 20 - 35℃; anschliessende Behandlung mit festem CO2;
4-Bromodiphenyl ether
101-55-3

4-Bromodiphenyl ether

diethyl ether
60-29-7

diethyl ether

propyllithium
2417-93-8

propyllithium

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
at 26℃; anschliessende Behandlung mit festem CO2;
4-Bromodiphenyl ether
101-55-3

4-Bromodiphenyl ether

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With diethyl ether; propyllithium anschliessend mit festem Kohlendioxid behandeln;
With n-butyllithium; diethyl ether anschliessend mit festem Kohlendioxid behandeln;
4-phenoxy benzaldehyde
67-36-7

4-phenoxy benzaldehyde

A

(4-phenoxyphenyl)methanol
2215-78-3

(4-phenoxyphenyl)methanol

B

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With potassium hydroxide at 60℃;
4-phenoxy benzaldehyde
67-36-7

4-phenoxy benzaldehyde

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With silver(l) oxide
With potassium permanganate
With rat hepatic microsomal aldehyde dehydrogenase; NAD In phosphate buffer; N,N-dimethyl-formamide at 37℃; pH=7.4; Enzyme kinetics; Dehydrogenation;
With potassium permanganate Alkaline aq. solution;
With sodium chlorite; potassium dihydrogenphosphate; 2-methyl-but-2-ene; water In tetrahydrofuran; tert-butyl alcohol Pinnick oxidation;
4-phenoxytoluene
1706-12-3

4-phenoxytoluene

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
With potassium permanganate; water
With sodium dichromate; sulfuric acid; acetic acid
4-phenoxybenzamide
29921-15-1

4-phenoxybenzamide

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

diethyl ether
60-29-7

diethyl ether

4-phenoxyiodobenzene
2974-94-9

4-phenoxyiodobenzene

phenyllithium
591-51-5

phenyllithium

A

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

B

5-iodo-2-phenoxy-benzoic acid
69199-91-3

5-iodo-2-phenoxy-benzoic acid

Conditions
ConditionsYield
at 20 - 35℃; anschliessende Behandlung mit festem CO2;
carbon dioxide
124-38-9

carbon dioxide

4-phenoxyiodobenzene
2974-94-9

4-phenoxyiodobenzene

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Conditions
ConditionsYield
(i) poly-4-lithium-styrene, Et2O, (ii) /BRN= 1900390/; Multistep reaction;
p-phenoxyphenyltellurium(IV) trichloride
36310-34-6

p-phenoxyphenyltellurium(IV) trichloride

A

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

B

4,4'-diphenoxy-1,1'-biphenyl
2519-16-6

4,4'-diphenoxy-1,1'-biphenyl

Conditions
ConditionsYield
With sodium hydroxide; lithium pentachloropalladate; carbon monoxide 1.) MeCN, 25 deg C, 20 h; 2.) H2O; Yield given. Multistep reaction;
4-phenoxy-phenyl magnesium bromide

4-phenoxy-phenyl magnesium bromide

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

phenol
108-95-2

phenol

1-carboxy-benzenediazonium sulfate-(4)

1-carboxy-benzenediazonium sulfate-(4)

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-phenoxybenzoyl chloride
1623-95-6

4-phenoxybenzoyl chloride

Conditions
ConditionsYield
With thionyl chloride; N,N-dimethyl-formamide at 70℃; for 3h;100%
With thionyl chloride In N,N-dimethyl-formamide at 70℃; for 3h;100%
With thionyl chloride at 90℃;99%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

(4-phenoxyphenyl)methanol
2215-78-3

(4-phenoxyphenyl)methanol

Conditions
ConditionsYield
Stage #1: 4-Phenoxybenzoic acid With sodium hydroxide; sodium tetrahydroborate; sulfuric acid In tetrahydrofuran; diethyl ether at 0 - 20℃; for 4h;
Stage #2: With methanol In tetrahydrofuran; diethyl ether at 0 - 20℃; for 0.5h;
100%
Stage #1: 4-Phenoxybenzoic acid With sodium tetrahydroborate; sulfuric acid In tetrahydrofuran; diethyl ether at 0 - 20℃; for 4h;
Stage #2: With methanol In tetrahydrofuran; diethyl ether at 0 - 20℃; for 0.5h;
100%
Stage #1: 4-Phenoxybenzoic acid With borane-THF In tetrahydrofuran at 20℃;
Stage #2: With hydrogenchloride In water
87%
benzyl (4S)-4-(tert-butoxycarbonyl)amino-5-[(2-methoxyethoxy)methoxy]pentanoate
299432-52-3

benzyl (4S)-4-(tert-butoxycarbonyl)amino-5-[(2-methoxyethoxy)methoxy]pentanoate

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

benzyl (4S)-5-(2-methoxyethoxy)methoxy-4-[(4-phenoxybenzoyl)amino]pentanoate
911050-53-8

benzyl (4S)-5-(2-methoxyethoxy)methoxy-4-[(4-phenoxybenzoyl)amino]pentanoate

Conditions
ConditionsYield
Stage #1: benzyl (4S)-4-(tert-butoxycarbonyl)amino-5-[(2-methoxyethoxy)methoxy]pentanoate With trifluoroacetic acid In dichloromethane; water at 0℃; for 0.5h;
Stage #2: 4-Phenoxybenzoic acid With 1-hydroxybenzotriazol-hydrate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 0℃;
100%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-chlorodiphenyl ether
7005-72-3

4-chlorodiphenyl ether

Conditions
ConditionsYield
With dichloromethane extract derived from 6percent aqueous hypochlorite/tetra-n-butylammonium bisulfate solution with pH value to 8-9 In dichloromethane at 20℃;100%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

tetramethyl ammoniumhydroxide
75-59-2

tetramethyl ammoniumhydroxide

C13H9O3(1-)*C4H12N(1+)

C13H9O3(1-)*C4H12N(1+)

Conditions
ConditionsYield
With water In ethanol at 0 - 20℃; for 0.0833333h;100%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

C20H18O3

C20H18O3

C33H26O5

C33H26O5

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;100%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

methyl 2-cyanoacetate
105-34-0

methyl 2-cyanoacetate

2-cyano-3-oxo-3-(4-phenoxy-phenyl)-propionic acid methyl ester
883560-03-0

2-cyano-3-oxo-3-(4-phenoxy-phenyl)-propionic acid methyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; diethyl dicarbonate In N,N-dimethyl-formamide99%
With N-ethyl-N,N-diisopropylamine; diethyl dicarbonate In N,N-dimethyl-formamide99%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-phenoxybenzoyl fluoride
370-12-7

4-phenoxybenzoyl fluoride

Conditions
ConditionsYield
With tetramethylammonium trifluoromethanethiolate In dichloromethane at 25℃; for 2h; Inert atmosphere;99%
With N,N,N',N'-tetramethyl-1,8-diaminonaphthalene; fluoro-N,N,N',N'-tetramethylformamidinium hexafluorophosphate In tetrahydrofuran at 20℃;
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-phenoxybenzoic acid succinimide ester
437708-50-4

4-phenoxybenzoic acid succinimide ester

Conditions
ConditionsYield
With pyridine; thionyl chloride In acetonitrile at 0 - 20℃; for 1h;98.4%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

diethyl (3-aminobenzyl)phosphonate
104139-11-9

diethyl (3-aminobenzyl)phosphonate

diethyl 3-(4-phenoxybenzamido)benzylphosphonate
1456602-22-4

diethyl 3-(4-phenoxybenzamido)benzylphosphonate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 16h;98%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

C16H14O5

C16H14O5

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 0 - 20℃; for 4h;97%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

N,N-dimethylethylenediamine
108-00-9

N,N-dimethylethylenediamine

N,N-dimethyl-2-(4-phenoxybenzamido)ethylamine

N,N-dimethyl-2-(4-phenoxybenzamido)ethylamine

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃;97%
4-tert-Butylaniline
769-92-6

4-tert-Butylaniline

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

N-(4-tert-butylphenyl)-4-phenoxybenzamide

N-(4-tert-butylphenyl)-4-phenoxybenzamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃;97%
2-amino-4-ethoxycarbonyl-pyridine
13362-30-6

2-amino-4-ethoxycarbonyl-pyridine

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

ethyl 2-(4-phenoxybenzamido)isonicotinate

ethyl 2-(4-phenoxybenzamido)isonicotinate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform at 50℃; Inert atmosphere;97%
ethanol
64-17-5

ethanol

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-phenoxybenzoic acid ethyl ester
31994-68-0

4-phenoxybenzoic acid ethyl ester

Conditions
ConditionsYield
With acetyl chloride for 3h; Reflux; Inert atmosphere;96%
With sulfuric acid for 72h; Heating;50%
With sulfuric acid
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

malononitrile
109-77-3

malononitrile

2-[hydroxy-(4-phenoxy-phenyl)-methylene]-malononitrile
330792-68-2

2-[hydroxy-(4-phenoxy-phenyl)-methylene]-malononitrile

Conditions
ConditionsYield
Stage #1: 4-Phenoxybenzoic acid With thionyl chloride for 1h; Heating / reflux;
Stage #2: malononitrile With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; toluene at -10 - 20℃;
96%
Stage #1: 4-Phenoxybenzoic acid With thionyl chloride for 1h; Reflux;
Stage #2: malononitrile With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; toluene at -10 - 20℃;
96%
Stage #1: 4-Phenoxybenzoic acid With thionyl chloride In toluene for 1h; Reflux;
Stage #2: malononitrile With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; toluene at 0 - 20℃;
96%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

diethyl (4-aminobenzyl)phosphonate
20074-79-7

diethyl (4-aminobenzyl)phosphonate

diethyl 4-(4-phenoxybenzamido)benzylphosphonate
1456602-21-3

diethyl 4-(4-phenoxybenzamido)benzylphosphonate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 16h;96%
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0 - 20℃; for 16h;96%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

2-(3,4-dimethoxyphenyl)-ethylamine
120-20-7

2-(3,4-dimethoxyphenyl)-ethylamine

N-(3,4-dimethoxyphenethyl)-4-phenoxybenzamide
143576-84-5

N-(3,4-dimethoxyphenethyl)-4-phenoxybenzamide

Conditions
ConditionsYield
Stage #1: 4-Phenoxybenzoic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride at 20℃; for 0.166667h;
Stage #2: 2-(3,4-dimethoxyphenyl)-ethylamine With triethylamine at 20℃;
95%
With hydrogenchloride In dichloromethane
1,4-dioxane
123-91-1

1,4-dioxane

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

1,4-dioxan-2-yl 4-phenoxybenzoate
1597710-67-2

1,4-dioxan-2-yl 4-phenoxybenzoate

Conditions
ConditionsYield
With iron(III)-acetylacetonate; di-tert-butyl peroxide at 120℃; for 24h; Schlenk technique;94%
3-(TRIFLUOROMETHYL)BENZYLAMINE
2740-83-2

3-(TRIFLUOROMETHYL)BENZYLAMINE

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-phenoxy-N-(3-trifluoromethyl-benzyl)-benzamide

4-phenoxy-N-(3-trifluoromethyl-benzyl)-benzamide

Conditions
ConditionsYield
With benzotriazol-1-ol; N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline In dichloromethane at 20℃; for 17.5h;93%
1,2,3,4-tetrahydronaphthalen-1-amine
2217-40-5

1,2,3,4-tetrahydronaphthalen-1-amine

4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

4-phenoxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide

4-phenoxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃;91%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

(3-aminophenyl)phosphonate de diethyle
89277-85-0

(3-aminophenyl)phosphonate de diethyle

diethyl 3-(4-phenoxybenzamido)phenylphosphonate
1456602-20-2

diethyl 3-(4-phenoxybenzamido)phenylphosphonate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; Inert atmosphere;90%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; Inert atmosphere;90%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

Cyclopentamine
1003-03-8

Cyclopentamine

N-cyclopentyl-4-phenoxybenzamide

N-cyclopentyl-4-phenoxybenzamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃;90%
4-Phenoxybenzoic acid
2215-77-2

4-Phenoxybenzoic acid

aniline
62-53-3

aniline

4-phenoxy-N-phenylbenzamide
864175-69-9

4-phenoxy-N-phenylbenzamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃;90%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃;90%

2215-77-2Relevant articles and documents

Suzuki?Miyaura coupling and O?arylation reactions catalysed by palladium(II) complexes of bulky ligands bearing naphthalene core, Schiff base functionality and biarylphosphine moiety

Arora, Aayushi,Kaushal, Jolly,Kumar, Arun,Nautiyal, Divyanshu,Oswal, Preeti,Singh, Siddhant

, (2022/01/19)

Schiff bases L1 [i.e., 2-(diphenylphosphino)-N-(naphthalen-1-ylmethylene)ethanamine], L2 [i.e., 2- (diphenylphosphino)-N-(naphthalen-2-ylmethylene)ethanamine], L3 [i.e., 2-(1-(2-(diphenylphosphino)ethylim- ino)ethyl)naphthalen-1-ol] and L4 [i.e., 2-((2-(diphenylphosphino)ethylimino)methyl)naphthalen-1-ol] have been synthesized using a straightforward methodology which involves a condensation reaction between H2N?CH2?CH2?PPh2 and appropriate carbonyl compound. Due to the presence of diphenylphosphine (?PPh2) moiety and >C = N? functionality, these compounds behave as ligands and undergo complexation reaction with palladium on treatment with Na2PdCl4 to yield the palladium(II) complexes (1–4). Ligands as well as complexes have been characterized using standard NMR spectroscopic techniques. ESI?MS and single crystal X?ray diffraction studies corroborate the structures of complexes. Crystal structures of complexes 1?3 reveal clearly that the geometry around Pd centre is distorted square planar. Ligands L1 and L2 are coordinated to Pd centre in bidentate (P, N type) mode, however, L3 and L4 act as a tridentate (P,N,O type) ligand and bind with metal in anionic mode. The Pd P and Pd N bond distances in complexes 1?3 are in the ranges 2.204?2.212 ? and 2.023?2.072 ?, respectively. Complex 3 [i.e., PdCl(L3?H)] also has a Pd-O bond, the length of which is found to be 2.009(3) ?. All the complexes have potential for catalysing O-arylation (C-O coupling) of phenol and Suzuki-Miyaura coupling (SMC) reactions. Both bromoarenes and chloroarenes can be used as substrates in Suzuki coupling and converted into biaryl derivatives. For O-arylation reactions of phenol, bromoarenes are used as arylating agents. For catalysis of such reactions (i.e., C-O coupling), high (0.1 mol%) catalyst loading is required. However, Suzuki reactions require low (0.001 mol%) loading of catalysts to occur with bromoarenes and give the products. The high potential of the complexes is also evident from the fact that they also convert different aryl chlorides into the coupled products in Suzuki coupling. 31P{1H} NMR data reveal that the electronic environments of nuclei of phosphorous donors are closely similar in all the four ligands. Similar magnitude of deshielding of the 31P{1H} signals in all the complexes indicate that, while forming the dative bond, the P donor of all the ligands transfer the electron density to the palladium to a similar extent. Hence, the electronic effects created by the ligands through the phosphorous donor are similar in all the complexes. Therefore, it is inferred that variation in their catalytic performance is because of difference in the binding mode of the ligand and/or minor alteration in the architecture of organic ligand. Amongst them, complex 2 shows the highest catalytic activity, and the least active catalyst is complex 3 for C-C coupling reactions. For C-O coupling reactions, the efficiencies of complexes 1 and 2 are slightly higher than those of complexes 3 and 4.

Photoinduced FeCl3-Catalyzed Alkyl Aromatics Oxidation toward Degradation of Polystyrene at Room Temperature?

Zhang, Guoxiang,Zhang, Zongnan,Zeng, Rong

supporting information, p. 3225 - 3230 (2021/09/28)

While polystyrene is widely used in daily life as a synthetic plastic, the subsequently selective degradation is still very challenging and highly required. Herein, we disclose a highly practical and selective reaction for the catalytically efficient oxidation of alkyl aromatics (including 1°, 2°, and 3° alkyl aromatics) to carboxylic acids. While dioxygen was used as the sole terminal oxidant, this protocol was catalyzed by the inexpensive and readily available ferric compound (FeCl3) with irradiation of visible light (blue LEDs) under only 1 atmosphere of O2 at room temperature. This system could further facilitate the selective degradation of polystyrene to benzoic acid, providing an important and practical tool to generate high-value chemical from abundant polystyrene wastes.

Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT

Yagci, Semih,Gozelle, Mahmut,Kaya, Selen Gozde,Ozkan, Yesim,Aksel, Ahmet Bugra,Bakar-Ates, Filiz,Dundar, Yasemin,Eren, Gokcen

, (2021/01/07)

Sirtuins (SIRTs) are a class of nicotinamide adenine dinucleotide (NAD+)-dependent protein histone deacetylases (HDACs) that are evolutionarily conserved from bacteria to mammals. This group of enzymes catalyses the reversible deacetylation of lysine residues in the histones or non-histone substrates using NAD+ as a cosubstrate. Numerous studies have demonstrated that the aberrant enzymatic activity of SIRTs has been linked to various diseases like diabetes, cancer, and neurodegenerative disorders. Previously, we performed a pharmacophore-based virtual screening campaign and an aryloxybenzamide derivative (1) displaying SIRT1/2 inhibitory effect was identified as a hit compound. In the current study, the hit-to-lead optimization on the hit compound was explored in order to improve the SIRT binding and inhibition. Fourteen compounds, ten of which were new, have been synthesized and subjected to in vitro biological evaluation for their inhibitory activity against SIRT1-3. By the structural modifications performed, a significant improvement was observed in selective SIRT1 inhibition for ST01, ST02, and ST11 compared to that of the hit compound. The highest SIRT2 inhibitory activity was observed for ST14, which was designed according to compatibility with pharmacophore model developed for SIRT2 inhibitors and thus, providing the interactions required with key residues in SIRT2 active site. Furthermore, ST01, ST02, ST11, and ST14 were subjected to in vitro cytotoxicity assay against MCF-7 human breast cancer cell line to determine the influence of the improvement in SIRT1/2 inhibition along with the structural modifications on the cytotoxic properties of the compounds. The cytotoxicity of the compounds was found to be correlated with their SIRT inhibitory profiles indicating the effects of SIRT1/2 inhibition on cancer cell viability. Overall, this study provides structural insights for further inhibitor improvement.

Oxidative α-C-C Bond Cleavage of 2° and 3° Alcohols to Aromatic Acids with O2at Room Temperature via Iron Photocatalysis

Zhang, Zongnan,Zhang, Guoxiang,Xiong, Ni,Xue, Ting,Zhang, Junjie,Bai, Lu,Guo, Qinyue,Zeng, Rong

, p. 2915 - 2920 (2021/05/05)

The selective α-C-C bond cleavage of unfunctionalized secondary (2°) and tertiary alcohols (3°) is essential for valorization of macromolecules and biopolymers. We developed a blue-light-driven iron catalysis for aerobic oxidation of 2° and 3° alcohols to acids via α-C-C bond cleavages at room temperature. The first example of oxygenation of the simple tertiary alcohols was reported. The iron catalyst and blue light play critical roles to enable the formation of highly reactive O radicals from alcohols and the consequent two α-C-C bond cleavages.

Novel fatty acid-thiadiazole derivatives as potential antimycobacterial agents

Mali, Jaishree K.,Sutar, Yogesh B.,Pahelkar, Akshata R.,Verma, Preeti M.,Telvekar, Vikas N.

, p. 174 - 181 (2019/11/03)

The discovery of antibiotics around the middle twentieth century led to a decrease in the interest in antimycobacterial fatty acids. In order to re-establish the importance of naturally abundant fatty acid, a series of fatty acid-thiadiazole derivatives were designed and synthesized based on molecular hybridization approach. In vitro antimycobacterial potential was established by a screening of synthesized compounds against Mycobacterium tuberculosis H37Rv strain. Among them, compounds 5a, 5d, 5h, and 5j were the most active, with compound 5j exhibiting minimum inhibitory concentration of 2.34?μg/ml against M.tb H37Rv. Additionally, the compounds were docked to determine the probable binding interactions and understand the mechanism of action of most active molecules on enoyl-acyl carrier protein reductases (InhA), which is involved in the mycobacterium fatty acid biosynthetic pathway.

4-phenoxybenzoic acid synthesis method

-

Paragraph 0015-0020, (2019/11/21)

The invention relates to the technical field of chemical industry synthesis, and particularly discloses a 4-phenoxybenzoic acid synthesis method, which comprises: carrying out a mixing heating reaction on phenol as a raw material, sodium hydroxide and water to obtain a sodium phenolate solution; slowly adding the sodium phenolate solution into a mixture of tetrahydronaphthalene and p-chlorobenzoicacid in a dropwise manner while heating, and carrying out a thermal insulation reaction; after completing the reaction, cooling the reaction liquid, filtering, washing the obtained solid, filtering,mixing by adding clear water, adjusting the pH value, and filtering to obtain crude and wet 4-phenoxybenzoic acid; and dissolving the crude and wet 4-phenoxybenzoic acid in ethanol, adsorbing with active carbon, filtering, cooling, and filtering to obtain the product. According to the present invention, the process route is simple and easy to operate, the reaction can be completed in one step, thestarting raw material is simple and cheap, and is easy to obtain, the generated waste water is less, and the method is suitable for industrial production, and is a completely-new synthesis route.

Design, synthesis, and structure-activity relationship studies of novel diaryl ether amides as potential antitumor agents

Zheng, Man-Yi,Huang, Zhi-Ning,Yang, Shao-Mei,Han-Liang,Lu-Xu,Wang, Bao-Rui,Wang, Li-Juan,Wang, Hai-Li,Li, Shan-Hua,Li, Fu-Nan

, p. 727 - 736 (2019/05/22)

Sorafenib is a drug that has been verified to be effective on hepatoma cells. Three series of diaryl ethers have been designed and synthesized based on the structure of sorafenib. The 5m compound shows better inhibitory potency against HepG2 cells (IC50 = 1.96 μM) than sorafenib (IC50 = 9.61μM). These results have been verified with MTT assay and colony-forming assay. Moreover, compound 5m exhibits good antitumor activities against PLC/PRF5, HeLa, A549, and HT-29 cell lines. The excellent bioactivity of compound 5m confirms that a single optical conformation is superior to the racemate. A western blotting analysis indicates that compound 5m induces the apoptosis of HepG2 cells by enhancing the protein levels of p21 and Cl-caspase3.

Visible-Light-Mediated Hydroxycarbonylation of Diazonium Salts

Gosset, Cyrille,Pellegrini, Sylvain,Jooris, Romain,Bousquet, Till,Pelinski, Lydie

, p. 3401 - 3405 (2018/08/06)

A visible light-promoted catalytic photoredox hydroxycarbonylation was achieved on aryl diazonium salts whether preformed or generated in situ from the corresponding anilines. This strategy allows a straightforward access to a variety of carboxylic acids under mild conditions. (Figure presented.).

Method for preparing ibrutinib

-

, (2018/03/26)

The invention discloses a method for preparing ibrutinib. The method includes the following steps of 1, preparation of IB-A, 2, preparation of IB-B, 3, preparation of IB-C, 4, preparation of IB-D, 5,preparation of IB-E, 6, preparation of IB-F, 7, preparation of IB-G, 8, preparation of IB-H, and 9, preparation of IB-J. The method has the advantages that the process is mature and stable, the quality of the product is stable, the production process is safe and reliable, and the ibrutinib is suitable for industrial production.

Synthesis and structure–activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways

Huang, Zhi-Ning,Liang, Han,Qiao, Hong,Wang, Bao-Rui,Qu, Ning,Li, Hua,Zhou, Run-Run,Wang, Li-Juan,Li, Shan-Hua,Li, Fu-Nan

, p. 1149 - 1161 (2018/07/21)

Guided by bioisosterism and pharmacokinetic parameters, we designed and synthesized a series of novel benzamide derivatives. Preliminary in vitro studies indicated that compounds 10b and 10j show significant inhibitory bioactivity in HepG2 cells (IC50 values of 0.12 and 0.13?μM, respectively). Compounds 10b and 10j induced the expression of HIF-1α protein and downstream target gene p21, and upregulated the expression of cleaved caspase-3 to promote tumor cells apoptosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2215-77-2